Insulet Financial Statements From 2010 to 2024

PODD Stock  USD 262.93  0.93  0.35%   
Insulet financial statements provide useful quarterly and yearly information to potential Insulet investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Insulet financial statements helps investors assess Insulet's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Insulet's valuation are summarized below:
Gross Profit
805.6 M
Profit Margin
0.2122
Market Capitalization
18.4 B
Enterprise Value Revenue
9.5463
Revenue
B
There are over one hundred nineteen available fundamental trends for Insulet, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Insulet's regular performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 9.8 B. The current year's Enterprise Value is expected to grow to about 10.3 B

Insulet Total Revenue

1.78 Billion

Check Insulet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insulet's main balance sheet or income statement drivers, such as Interest Expense of 18.9 M, Other Operating Expenses of 1.6 B or Operating Income of 231 M, as well as many indicators such as Price To Sales Ratio of 16.14, Dividend Yield of 0.0 or PTB Ratio of 20.25. Insulet financial statements analysis is a perfect complement when working with Insulet Valuation or Volatility modules.
  
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Insulet Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.7 B2.6 B1.1 B
Slightly volatile
Cash739.4 M704.2 M390.2 M
Slightly volatile
Other Assets0.951.027.3 M
Slightly volatile
Cash And Short Term Investments739.4 M704.2 M390.2 M
Slightly volatile
Common Stock Shares Outstanding44.7 M73.6 M54.8 M
Slightly volatile
Liabilities And Stockholders Equity2.7 B2.6 B1.1 B
Slightly volatile
Total Liabilities1.9 B1.9 B808.4 M
Slightly volatile
Total Current Assets1.7 B1.6 B663.5 M
Slightly volatile
Short and Long Term Debt Total1.5 B1.4 B653.4 M
Slightly volatile
Total Current Liabilities473.8 M451.2 M158 M
Slightly volatile
Short Term Debt49.9 M52.9 M52.2 M
Very volatile
Property Plant And Equipment Net727.4 M692.8 M267.1 M
Slightly volatile
Accounts Payable19.7 M19.2 M23.4 M
Slightly volatile
Non Current Assets Total1.1 BB410.9 M
Slightly volatile
Non Currrent Assets Other142.3 M135.5 M49.8 M
Slightly volatile
Common Stock Total Equity120.8 K115 K71.7 K
Slightly volatile
Non Current Liabilities Total1.5 B1.4 B652.7 M
Slightly volatile
Other Current Assets122.2 M116.4 M37.1 M
Slightly volatile
Property Plant And Equipment GrossB958.1 M330.9 M
Slightly volatile
Common Stock59.5 K115 K67.6 K
Slightly volatile
Other Liabilities5.4 M9.5 M6.4 M
Slightly volatile
Long Term Debt1.4 B1.4 B634.8 M
Slightly volatile
Net Receivables377.7 M359.7 M106.8 M
Slightly volatile
Inventory422.7 M402.6 M128.9 M
Slightly volatile
Property Plant Equipment724.4 M689.9 M267 M
Slightly volatile
Good Will44.1 M59.5 M40 M
Slightly volatile
Long Term Debt Total1.7 B1.6 B671.2 M
Slightly volatile
Capital Surpluse899.1 M1.2 B827.7 M
Slightly volatile
Non Current Liabilities Other39.8 M37.9 M13.5 M
Slightly volatile
Intangible Assets103.6 M98.7 M32.4 M
Slightly volatile
Capital Lease Obligations230 K242.1 K1.8 M
Slightly volatile
Short and Long Term Debt46.9 M49.4 M141.4 M
Slightly volatile
Net Invested Capital1.4 B2.1 BB
Slightly volatile
Net Working Capital856.9 M1.1 B631.2 M
Slightly volatile
Capital Stock102.5 K115 K76.6 K
Slightly volatile

Insulet Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses1.6 B1.5 B636 M
Slightly volatile
Research Development215.2 M205 M93.6 M
Slightly volatile
Total Operating Expenses986.9 M939.9 M390.7 M
Slightly volatile
Income Tax Expense8.7 M8.3 M3.2 M
Slightly volatile
Selling And Marketing Expenses223.5 M212.9 M121.8 M
Slightly volatile
Depreciation And Amortization76.4 M72.8 M30.4 M
Slightly volatile
Selling General Administrative699.7 M666.4 M233.2 M
Slightly volatile
Total Revenue1.8 B1.7 B672.2 M
Slightly volatile
Cost Of Revenue564.1 M537.2 M245.4 M
Slightly volatile
Tax Provision9.6 M9.1 M2.5 M
Slightly volatile
Interest Income30.3 M28.9 M12.1 M
Pretty Stable
Reconciled Depreciation47.7 M70.2 M29.9 M
Slightly volatile

Insulet Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow724.2 M689.7 M304.8 M
Slightly volatile
Depreciation76.4 M72.8 M30.4 M
Slightly volatile
Capital Expenditures58.2 M75.6 M71.1 M
Slightly volatile
End Period Cash Flow739.4 M704.2 M346.5 M
Slightly volatile
Change To Liabilities158.8 M151.2 M41.3 M
Slightly volatile
Stock Based Compensation50.7 M48.3 M27 M
Slightly volatile
Change To Netincome40.7 M55.1 M36.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio16.148.917916.3485
Slightly volatile
Days Sales Outstanding73.5877.361757.9558
Pretty Stable
Stock Based Compensation To Revenue0.0270.02850.054
Slightly volatile
Capex To Depreciation0.991.03853.0834
Very volatile
EV To Sales18.449.356719.5748
Slightly volatile
Inventory Turnover1.271.33435.0436
Slightly volatile
Days Of Inventory On Hand287274142
Slightly volatile
Payables Turnover29.3827.979211.1443
Slightly volatile
Sales General And Administrative To Revenue0.170.180.3373
Slightly volatile
Research And Ddevelopement To Revenue0.110.120814.4806
Slightly volatile
Capex To Revenue0.04230.04457.3949
Slightly volatile
Cash Per Share19.0710.481611.3484
Very volatile
Days Payables Outstanding12.3913.045463.2867
Slightly volatile
Intangibles To Total Assets0.05520.05810.1222
Slightly volatile
Current Ratio3.333.508230.3753
Slightly volatile
Receivables Turnover5.014.71817.0388
Pretty Stable
Graham Number25.1226.439523.4344
Slightly volatile
Capex Per Share1.031.08391.7597
Pretty Stable
Revenue Per Share25.5524.330810.4918
Slightly volatile
Interest Debt Per Share21.9120.867110.4407
Slightly volatile
Debt To Assets0.410.54840.5567
Slightly volatile
Operating Cycle264351252
Pretty Stable
Days Of Payables Outstanding12.3913.045463.2867
Slightly volatile
Quick Ratio2.492.615929.8104
Slightly volatile
Net Income Per E B T1.00.96130.9126
Slightly volatile
Cash Ratio1.481.560729.0064
Slightly volatile
Cash Conversion Cycle193338185
Very volatile
Days Of Inventory Outstanding287274142
Slightly volatile
Days Of Sales Outstanding73.5877.361757.9558
Pretty Stable
Fixed Asset Turnover4.52.44964.4817
Slightly volatile
Debt Ratio0.410.54840.5567
Slightly volatile
Price Sales Ratio16.148.917916.3485
Slightly volatile
Asset Turnover0.460.65570.6606
Pretty Stable

Insulet Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.8 B9.3 B6.7 B
Slightly volatile
Enterprise Value10.3 B9.8 BB
Slightly volatile

Insulet Fundamental Market Drivers

Forward Price Earnings67.5676
Cash And Short Term Investments704.2 M

Insulet Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Insulet Financial Statements

Insulet stakeholders use historical fundamental indicators, such as Insulet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Insulet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Insulet's assets and liabilities are reflected in the revenues and expenses on Insulet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Insulet. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue15.4 M16.2 M
Total Revenue1.7 B1.8 B
Cost Of Revenue537.2 M564.1 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.18  0.17 
Research And Ddevelopement To Revenue 0.12  0.11 
Capex To Revenue 0.04  0.04 
Revenue Per Share 24.33  25.55 
Ebit Per Revenue 0.13  0.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.46
Earnings Share
5.86
Revenue Per Share
28.341
Quarterly Revenue Growth
0.257
Return On Assets
0.0757
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.